Does Impella Support Really Prevent Catastrophe?∗

by Joel P. Giblett, MD
Published 2020-04-01

Cardioprotection for Acute MI in Light of the CONDI2/ERIC-PPCI Trial: New Targets Needed

by Joel P Giblett, Heerajnarain Bulluck
Published 2020-08-01

Starting My Career as a Cardiologist During COVID-19

by Joel P. Giblett, BM, BSc, MD
Published 2020-08-01

Are Vasopressors an Enemy of the Coronary Arteries?∗

by Maria Rubini Gimenez, MD, Joel P. Giblett, MD
Published 2019-08-01

Iatrogenic Aortocoronary Dissection During Percutaneous Coronary Intervention

by John Hung, MBChB, Joel P. Giblett, MD, BM, BSc
Published 2021-01-01

Patent Foramen Ovale Closure in 2019

by Joel P Giblett, Omar Abdul-Samad, Leonard M Shapiro, Bushra S Rana, Patrick A Calvert
Published 2019-01-01

Patent Foramen Ovale Closure: State of the Art

by Joel P Giblett, Lynne K Williams, Stephen Kyranis, Leonard M Shapiro, Patrick A Calvert
Published 2020-11-01

Glucagon-Like Peptide-1

by Joel P. Giblett, BM, BSc, Sophie J. Clarke, BSc, David P. Dutka, MD, Stephen P. Hoole, MA, DM
Published 2016-06-01

A Giant Saphenous Vein Graft Aneurysm Treated With Percutaneous Closure

by Pawel Klementowicz, MD, Joel P. Giblett, MD, Sanjay K.B. Agrawal, MD, Leonard M. Shapiro, MD, Patrick A. Calvert, MA, PhD
Published 2019-12-01

GLP-1 vasodilatation in humans with coronary artery disease is not adenosine mediated

by Muhammad Aetesam-ur-Rahman, Joel P. Giblett, Bharat Khialani, Stephen Kyranis, Sophie J. Clarke, Tian X. Zhao, Denise M. Braganza, Sarah C. Clarke, Nick E. J. West, Martin R. Bennett, Stephen P. Hoole
Published 2021-05-01